Financials
- Market Capitalization 437.17 M
- Employee 71
- Founded 2010
- CEO N/A
- Website www.rezolutebio.com
- Headquarter Nevada, United States
- FIGI BBG001XWWHL4
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-3.67
市销率
—
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 3004 | DNA Ginkgo Bioworks Holdings, Inc. Class A Common Stock | 6.84 USD | -2.84% | -5.66% | -25.25% | -22.97% | 440.09 M USD | ||
| 3005 | GALT Galectin Therapeutics Inc. - Common Stock | 4.36 USD | -2.68% | +5.31% | +47.30% | -2.68% | 439.70 M USD | ||
| 3020 | BNTC Benitec Biopharma Inc. - Common Stock | 12.60 USD | -2.17% | -1.18% | +2.52% | -24.14% | 432.86 M USD | ||
| 3027 | CMPX Compass Therapeutics, Inc. - Common Stock | 2.37 USD | -2.47% | -4.05% | +25.40% | -30.09% | 426.81 M USD |